Please login to the form below

Not currently logged in
Email:
Password:

Amylin

This page shows the latest Amylin news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca and its diabetes plans

AstraZeneca and its diabetes plans

This was then expanded in 2012 when the alliance acquired Amylin, gaining the rights to a portfolio of products for type 2 diabetes, including the long-acting exenatide franchise (Byetta and

Latest news

More from news
Approximately 2 fully matching, plus 34 partially matching documents found.

Latest Intelligence

  • Interview: Christopher Boulton, AstraZeneca Interview: Christopher Boulton, AstraZeneca

    This was then expanded in 2012 when the alliance acquired Amylin, gaining the rights to a portfolio of products for type 2 diabetes, including the exenatide franchise (Byetta and Bydureon).

  • Case study: Educating HCPs and patients about diabetes

    Campaign:Diabetes Close to the Heart. Timescale:January, 2010 to November, 2010. Chandler Chicco Agency, with Amylin Pharmaceuticals, Inc. ... Extending education beyond the live performance, CCA worked with Amylin to develop filmed adaptations of the

  • Weighty matters

    Additionally, the Alliance has grown into a multi-funder initiative and has received funding from Amylin Pharmaceuticals and Allergan.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Adocia names senior members of new US subsidiary Adocia names senior members of new US subsidiary

    Bruce has also held position at Amylin Pharmaceuticals, where he was in charge of Bydureon's phase III studies and safety analysis, a once weekly GLP-1 injectable formulation. ... Daly's experience in the diabetes field also includes several years at

  • Profil Institute appoints former Amylin CEO Profil Institute appoints former Amylin CEO

    Bradbury is an experienced figure in the life science industry, serving as CEO of Amylin from 2007 to 2012 until its acquisition by Bristol-Myers Squibb.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics